Infectious Disease Diagnostics constitute more than 40 percent of the Global INAAT Market

Reportstack has announced a new market research publication on Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market which finds infectious disease diagnostics constitute more than 40 percent of the Global INAAT Market. The analysis is for the forecast period 2014-2018.

The market demand for infectious disease diagnosis is much higher due to the high incidence of various types of diseases across the world. In addition, the other parameters that increase the need for these tests in the market are the disability-adjusted life years lost per year and the huge economic burden due to infectious diseases. Some of the diseases targeted based on the INAAT platform include chlamydia, gonorrhea, HBV, HSV 1&2, HIV-1, HPV, and Trichomonas vaginalis.

High incidence of infectious diseases such as sexually transmitted diseases, hospital-acquired infections, and food-borne pathogens leading to high mortality rates is driving the Global INAAT market for Infectious Disease Diagnostics.

In 2013, the Infectious Disease Diagnostics segment held the largest share in the Global INAAT market, and this trend will be continuing during the forecast period owing to the demand for new diagnostic devices for many infectious diseases.

To determine the scenario for these vendors in the next 3-4 years, analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentation, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance. 

To view the table of contents and know more details please visit Infectious Disease Diagnostics constitute more than 40 percent of the Global INAAT Market report.